Position in GILD
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$274,789
-$28,340 QoQ
Shares Held
2,175
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#1,714
of 2,266 holders
Holding Since
Sep 2023
9 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026KPP Advisory Services LLC holds $13,310,017 across 9 Drug Manufacturers - General names. GILD ranks #7 (2.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
2,871 | $3,443,563 | |
| 2 | JNJ |
Johnson & Johnson
|
13,304 | $3,378,816 | |
| 3 | ABBV |
AbbVie Inc.
|
9,796 | $2,465,065 | |
| 4 | AMGN |
Amgen Inc
|
5,655 | $2,047,788 | |
| 5 | MRK |
Merck & Co., Inc.
|
6,862 | $881,767 | |
| 6 | PFE |
Pfizer Inc
|
15,236 | $366,882 | |
| 7 | GILD |
Gilead Sciences, Inc.
This page
|
2,175 | $274,789 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
4,213 | $242,753 |
All Filings in GILD
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $274,789 | 2,175 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $303,129 | 2,175 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $276,165 | 2,250 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $248,085 | 2,235 | Shares | Sole | 2025-11-03 | |
| 2025-06-30 | $251,120 | 2,265 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $255,361 | 2,279 | Shares | Sole | 2025-04-23 | |
| 2024-12-31 | $227,045 | 2,458 | Shares | Sole | 2025-01-24 | |
| 2024-09-30 | $206,246 | 2,460 | Shares | Sole | 2024-11-06 | |
| 2023-09-30 | $220,998 | 2,949 | Shares | Sole | 2023-11-14 | |
| No filing history on record for this holder in this stock. | ||||||